Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension.

Publication Year: 2019

DOI:
10.1111/cea.13331

PMCID:
PMC6849700

PMID:
30570787

Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST MW reports honoraria from Allergopharma GmbH & Co. KG for consulting and speaker activities outside the submitted work. BK and MR report personal fees from Allergopharma GmbH & Co. KG outside the submitted work. The remaining authors declare that they have no relevant conflicts of interest."

Evidence found in paper:

"Funding information"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025